Syneos Health, Inc.
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinic…
Medical - Diagnostics & Research
US, Morrisville [HQ]
SYNH/Financial Reporting
Income Statements
12 Sheets · Starting from 2011In Million USD. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 655.00 | 868.00 | 995.00 | 1,178.00 | 1,399.00 | 1,610.00 | 2,672.00 | 4,390.00 | 4,675.00 | 4,415.00 | 5,212.00 | 5,393.00 | |
|
EPS
|
-1.15 | -1.14 | -0.80 | -0.44 | 2.02 | 2.08 | -1.85 | 0.23 | 1.27 | 1.85 | 2.26 | 2.57 | |
| Diluted in mil. | -1.14 | -1.13 | -0.80 | -0.44 | 1.95 | 2.03 | -1.85 | 0.23 | 1.25 | 1.83 | 2.24 | 2.54 | |
|
Profit
|
157.00 | 190.00 | 220.00 | 294.00 | 372.00 | 403.00 | 620.00 | 955.00 | 1,029.00 | 1,017.00 | 1,218.00 | 1,254.00 | |
| Gross Margin | 23.96 | 21.88 | 22.12 | 25.00 | 26.61 | 25.07 | 23.23 | 21.77 | 22.03 | 23.05 | 23.37 | 23.26 | |
| Pre Tax | -94.00 | -94.00 | -30.00 | -28.00 | 130.00 | 134.00 | -111.00 | 57.00 | 101.00 | 203.00 | 315.00 | 314.00 | |
| Profit Margin | -14.35 | -10.92 | -3.08 | -2.39 | 9.36 | 8.33 | -4.19 | 1.30 | 2.18 | 4.61 | 6.05 | 5.83 | |
| ETR | 36.76 | 37.68 | -35.36 | 16.78 | 10.63 | 16.02 | -23.77 | 57.59 | -29.05 | 5.34 | 25.49 | 15.28 | |
| Net | -59.00 | -59.00 | -41.00 | -23.00 | 117.00 | 112.00 | -138.00 | 24.00 | 131.00 | 192.00 | 234.00 | 266.00 | |
| Profit Margin | -9.08 | -6.81 | -4.17 | -1.99 | 8.37 | 6.99 | -5.18 | 0.55 | 2.81 | 4.37 | 4.50 | 4.94 | |
| EBITDA | 52.00 | 84.00 | 102.00 | 149.00 | 218.00 | 219.00 | 319.00 | 581.00 | 567.00 | 578.00 | 656.00 | 699.00 | |
| EBITDA Margin | 8.01 | 9.71 | 10.27 | 12.69 | 15.59 | 13.62 | 11.96 | 13.24 | 12.13 | 13.09 | 12.59 | 12.98 | |
| Operating Income | -40.00 | -37.00 | 31.00 | 63.00 | 152.00 | 155.00 | -28.00 | 160.00 | 324.00 | 293.00 | 389.00 | 403.00 | |
| Operating Margin | -6.13 | -4.32 | 3.16 | 5.40 | 10.89 | 9.65 | -1.08 | 3.65 | 6.94 | 6.64 | 7.47 | 7.48 | |
| Interest Income | - - | - - | - - | - - | - - | - - | 1.00 | 3.00 | 7.00 | - - | - - | 1.00 | |
| Loss | -658.00 | -866.00 | -951.00 | -1,083.00 | -1,239.00 | -1,438.00 | -2,513.00 | -4,114.00 | -4,334.00 | -4,062.00 | -4,800.00 | -4,933.00 | |
| Cost of Revenue | -498.00 | -678.00 | -774.00 | -884.00 | -1,026.00 | -1,206.00 | -2,051.00 | -3,434.00 | -3,645.00 | -3,398.00 | -3,994.00 | -4,138.00 | |
|
Operating Expenses
|
-159.00 | -188.00 | -176.00 | -199.00 | -212.00 | -231.00 | -462.00 | -679.00 | -688.00 | -664.00 | -806.00 | -794.00 | |
| R&D | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| G&A | - - | - - | - - | - - | - - | - - | - - | -406.00 | - - | - - | - - | - - | |
| SG&A | -95.00 | -109.00 | -117.00 | -145.00 | -156.00 | -172.00 | -282.00 | -406.00 | -446.00 | -442.00 | -570.00 | -547.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -64.00 | -78.00 | -58.00 | -54.00 | -56.00 | -59.00 | -179.00 | -273.00 | -242.00 | -222.00 | -235.00 | -247.00 | |
| Interest Expenses | -65.00 | -62.00 | -60.00 | -53.00 | -15.00 | -12.00 | -63.00 | -130.00 | -129.00 | -90.00 | -79.00 | -80.00 | |
| Other Expenses | -16.00 | -34.00 | -13.00 | -62.00 | -11.00 | -23.00 | -207.00 | -91.00 | -222.00 | -89.00 | -74.00 | -88.00 | |
|
WA Shares Outstanding
|
51.00 | 51.00 | 52.00 | 53.00 | 57.00 | 54.00 | 74.00 | 103.00 | 103.00 | 104.00 | 103.00 | 102.00 | |
| Diluted | 52.00 | 52.00 | 52.00 | 53.00 | 60.00 | 55.00 | 74.00 | 104.00 | 105.00 | 105.00 | 105.00 | 103.00 |